Aphelion Cardeation II, LLC
Late investment periodEmerging manager
Late investment period: first sale Jun 2022, per Form D (fund age approximates vintage)
- Vintage
- 2022
- Fund size
- $42.92M (Form D)
- Stages
- Not stated
- Sectors
- Medical devices, Digital health
- Regions
- Not stated
01 · Thesis
Aphelion Capital is a healthcare venture firm investing in early and mid stage medical device and digital health companies. It backs capital efficient medical technologies and services that improve patient outcomes at the same or lower cost to the healthcare system.Inferred from the firm's website
02 · Initial check
$429K to $715K (estimated from fund size)
Estimated from Form D
03 · Who to approach
Named on this fund's Form D
- Edwin Scheetz, III, Manager of Aphelion Capital, LLC, Manager of Aphelion Cardeation II, LLC
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideAphelion Capital is a healthcare venture capital firm investing in capital efficient products and services that improve patient outcomes at the same or lower cost to the healthcare system.
Aphelion Capital is a healthcare venture capital firm investing in capital efficient products and services that improve patient outcomes at the same or lower cost to the healthcare system.
https://www.aphelioncapital.net/
06 · Sources
Last verified: Oct 28, 2026